RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > FDA Lays Groundwork for Study of Behaviors of Consumers and Healthcare Professionals

FDA Lays Groundwork for Study of Behaviors of Consumers and Healthcare Professionals

Posted 07 November 2013 | By Alexander Gaffney, RAC

A new contract announcement just issued by the US Food and Drug Administration (FDA) says it is looking for a contract partner with which to conduct behavioral research on how consumers and healthcare professionals react to promotional materials and labeling.

The notice, known as a Request for Information (RFA), is intended to identify companies capable of conducting market research for FDA in the area of behavioral research.

"The Agency is interested in organizations with the ability to assess consumer and healthcare professional responses to FDA products and their promotion and labeling through surveys or other methods," it states.

The term "FDA products," however, goes undefined, and it is unclear if it refers to FDA-regulated products or FDA products such as communications and labeling changes mandated by the agency itself.

FDA does, however, have a long list of relevant experience it wants to see from potential partners, including experience with surveying consumers, eye tracking data collection, 5,000+ person surveys, web surveys, focus groups, data analysis, creating websites and print advertisements, publishing in peer-reviewed journals and creating video advertisements or programs.

FDA said the eventual project it has in mind could include as many as eight concurrent projects every year, but clarified that at this point, its notice is "for information and planning purposes only" and that FDA is not yet ready to solicit bids.

Contract Notice

Tags: Contract, study

Regulatory Focus newsletters

All the biggest regulatory news and happenings.